We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Other Articles |

Factors Concerned with Postoperative Emesis and Its Prevention with Thiethylperazine

William C. North, MD, PhD; Thomas H. Collawn, MD; A.B. Hudnell Jr., MD; C.R. Stephen, MD
JAMA. 1963;183(8):656-658. doi:10.1001/jama.1963.63700080001017.
Text Size: A A A
Published online


ONE OF THE OBJECTIONS to the use of antiemetics in the postanesthetic period has been their tendency to prolong return to consciousness or to induce a hypotensive episode.1 When 2-ethyl-mercapto-10- [3′-(1″methyl-piperazinyl-4″)-propyl-1′] phenothiazine, thiethylperazine (Torecan), was proposed as a drug which acted specifically on the vomiting centers without causing sedation or hypotension,2 it seemed that it was worthy of trial as a safe postoperative antiemetic.

It was evaluated by the use of a "blind" technique in which neither the individual administering the drug nor the observer knew what agent had been given. In no instance was the patient aware that he was part of a special study. The solutions were dispensed in 2 cc coded ampules. The codes were not broken until completion of the studies. The injections were all made intramuscularly.

In the initial series, 1,390 unselected surgical patients over the age of five were


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.